Investigator Driven Randomized Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare Associated and Hospital Acquired Gram-negative Blood Stream Infection (the GAME CHANGER trial) (2018–2025)
- Grant type:
- Shionogi & Company, Limited
- Researchers:
-
-
- Funded by:
- Shionogi & Company, Limited
